Acceleron Pharma competitorsClear all
Acceleron Pharma's top competitors include Supernus Pharmaceuticals, Theravance Biopharma, GBT (Global Blood Therapeutics) and Portola Pharmaceuticals.
| Save Comparison |  Supernus Pharmaceuticals Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system. |  Theravance Biopharma Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 2003 | Founding Date 2005 | Founding Date 1996 | Founding Date 2012 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Rockville, US HQ | Locations Dublin, IE HQ San Francisco, US | Locations South San Francisco, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 23737% increase | Employees 4486% increase | Employees 3637% increase | Employees 352106% increase | Employees 32429% increase |
Valuation ($) | Valuation ($) 4.9 b | Valuation ($) 1.2 b | Valuation ($) 1.6 b | Valuation ($) 3.9 b | Valuation ($) 1.4 b |
Twitter followers | Twitter followers 1.4 k | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.4 k | Twitter followers 952 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 20 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 29 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.1 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 93.1% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 373397 | Alexa Website Rank 487814 | Alexa Website Rank 399268 | Alexa Website Rank 488148 | Alexa Website Rank 501399 |
Employee Rating | Employee Rating 4.4 | Employee Rating 3.6 | Employee Rating N/A | Employee Rating 4.8 | Employee Rating 3.5 |
Financial | |||||
Revenue (est.) | Revenue (est.) $74m (FY, 2019) | Revenue (est.) $392.8m (FY, 2019) | Revenue (est.) $60.4m (FY, 2018) | Revenue (est.) $2.1m (FY, 2019) | Revenue (est.) $116.6m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $16.7m (FY, 2019) | Cost of goods $715k (FY, 2018) | Cost of goods $48k (FY, 2019) | Cost of goods $44.4m (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit $376.1m (FY, 2019) | Gross profit $59.7m (FY, 2018) | Gross profit $2.1m (FY, 2019) | Gross profit $72.3m (FY, 2019) |
Net income | Net income ($124.9m) (FY, 2019) | Net income $113.1m (FY, 2019) | Net income ($215.5m) (FY, 2018) | Net income ($266.8m) (FY, 2019) | Net income ($290.7m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 141.8m | Total funding raised $ 42m | Total funding raised $ 55m | Total funding raised $ 88.7m | Total funding raised $ 295.1m |
For sources of this data, please see the company profile
View company profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
448↑ 6% increase
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.
View companyTheravance Biopharma
HQ
Dublin, IE
Employees
363↑ 7% increase
Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase
Portola Pharmaceuticals is a biopharmaceutical company.
View company